60 DEGREES PHARMACEUTICALS, INC. (SXTPW) Return on equity 2023–2025
60 DEGREES PHARMACEUTICALS, INC. (SXTPW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-212.7%FY2025 · since FY2023: -77.3% → -212.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -212.7% | -15.7 pp |
| FY2024 | -196.9% | -119.6 pp |
| FY2023 | -77.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More SXTPW financial trends
SXTPW RevenueSXTPW Net incomeSXTPW Net marginSXTPW Gross profitSXTPW Gross marginSXTPW Operating incomeSXTPW Operating marginSXTPW Operating cash flowSXTPW Free cash flowSXTPW Capital expendituresSXTPW Stock buybacksSXTPW Dividends paidSXTPW Total assetsSXTPW Total liabilitiesSXTPW Shareholders’ equitySXTPW overview →